Open-Label Treatment With Citalopram in Patients With Irritable Bowel Syndrome: A Pilot Study

Background: This open-label pilot study investigated whether the selective serotonin reuptake inhibitor (SSRI) citalopram improves symptoms of irritable bowel syndrome (IBS), a functional gastrointestinal disorder with frequent psychiatric comorbidity. Method: Fifteen patients meeting Rome I criteri...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Masand, Prakash S., Gupta, Sanjay, Schwartz, Thomas L., Virk, Subhdeep, Hameed, Ahmad, Kaplan, David S.
Formato: Artigo
Idioma:Inglês
Publicado: Physicians Postgraduate Press, Inc. 2005
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1192434/
https://ncbi.nlm.nih.gov/pubmed/16163399
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares